Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atherosclerotic plaque pathogenesis associated transcript (APPAT)
- Target
- APPAT
- Molecular classification
- Long non-coding RNA
01
Overview
Atherosclerotic plaque pathogenesis associated transcript (APPAT, AC092683.1) is a long non-coding RNA identified through transcriptomic analysis of human atherosclerotic lesions[1][3]. It is not a protein-coding gene, enzymatic factor, receptor, or transporter, and there is no evidence it is currently targeted by therapeutic agents. Its expression may be altered in atherosclerotic tissue and could serve as a molecular marker associated with disease pathogenesis, but it lacks validated roles in signaling pathways or disease modulation. The existing evidence is insufficient to classify it as a canonical target for pharmacological intervention, and further research would be needed to clarify its biological significance and utility.
- Other names
- AC092683.1APPAT
02
Mechanism of action
Not applicable; no drugs or small molecules with a mechanism of action targeting APPAT/AC092683.1 are reported.
03
Biological functions
Proposed involvement in regulation of gene expression related to atherosclerosis pathogenesisMay participate in vascular endothelial or smooth muscle cell biology within plaques[1][3]Function remains largely uncharacterized due to lack of functional studies
04
Disease associations
Cardiovascular disease (specifically atherosclerosis and plaque development)[1][3]
05
Safety considerations
None reported; as a non-coding transcript, APPAT does not have direct safety or toxicity implications, though its use as a biomarker would require specificity validation.
06
Biomarkers
Potentially a biomarker for presence or progression of atherosclerotic plaques, if further validated[1]No clinically validated biomarker use
Beyond the preview
Go deeper on Atherosclerotic plaque pathogenesis associated transcript (APPAT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atherosclerotic plaque pathogenesis associated transcript (APPAT).